3-Chloro-6-pyrrol-1-yl-pyridazine

Catalog No. :
ACLSTA918
CAS No. :
5096-76-4
Molecular Formula :
C8H6ClN3
Molecular Weight :
179.61

IUPAC Name:3-chloro-6-(1H-pyrrol-1-yl)pyridazine

3-Chloro-6-pyrrol-1-yl-pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$94.00Login to see priceInquiryInquiry
5g98%$262.00Login to see priceInquiryInquiry
10g98%$406.00Login to see priceInquiryInquiry
25g98%$899.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-6-pyrrol-1-yl-pyridazine
IUPAC Name3-chloro-6-(1H-pyrrol-1-yl)pyridazine
MDL No.MFCD00828665
Molecular FormulaC8H6ClN3
Molecular Weight179.61
SMILESClC1=CC=C(N=N1)[N]2C=CC=C2
InChI KeyLQIVORYEWIDSDK-UHFFFAOYSA-N
Synonym3-Chloro-6-pyrrol-1-yl-pyridazine | 5096-76-4 | 3-Chloro-6-(1H-pyrrol-1-yl)pyridazine | 3-Chloro-6-pyrrol-1-ylpyridazine | Halobetasolpropionate | DTXSID70507298 | 3-Chloro-6-pyrrol-1-yl-pyridazin | MFCD00828665 | AKOS002683993 | DS-0098 | CS-0213406 | FT-0635539 | EN300-7358338
CAS No.5096-76-4
PubChem CID12698865

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLSTA918 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTDYX265 route compound structure diagram
    ACTDYX265135034-10-5
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLSTA918 route product structure diagram
    ACLSTA9185096-76-4
Inquiry

2. ACLSTA918 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLSTA918 route product structure diagram
    ACLSTA9185096-76-4
Inquiry

Comments (0)